Kusajili – Clinical trials directory

Result of your search per specialist: Prof Julian Sampson

Woman and Man Max 99 years
Cardiff University (UK) Update Il y a 4 ans

A randomised, double blind, placebo-controlled study of RAD001 (Everolimus) in the treatment of neurocognitive problems in tuberous sclerosis Background and study aims Tuberous sclerosis (TSC) is a genetic disorder affecting approximately 1 in 10,000 people. It is characterised by the development of tumours in many organs and can lead to se...

Country None
organs None
Specialty None

Closed trial

More information